Although only one-third of the CPs in PapMV-SrtA nanoparticles became coupled to the M2e or T20 peptide, a robust immune response was triggered and PapMV-SrtA-M2e was capable of protecting mice from an influenza challenge. Here, CAD is linked to influenza.